ACTRN12624000877583
Recruiting
未知
Evaluation of Community Pharmacists Management of patients with Acute exacerbations of Atopic Dermatitis (6 months to 65 years), Impetigo (12 months and above), Mild-Plaque Psoriasis and Herpes Zoster (18 years and above): PATH-DERM
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Herpes Zoster
- Sponsor
- The University of Newcastle
- Enrollment
- 22857
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Pharmacies and pharmacists recruited must meet the eligibility criteria (defined below) to participate in the study, reflecting the criteria set by the Authority under Section 10 Poisons and Therapeutic Good Act 1966 Clauses 170 and 171 of the Poisons and Therapeutic Goods Regulation 2208\.
- •Community pharmacies
- •A community pharmacy in NSW or ACT must have a service room, consulting room, or area consistent with the following:
- •An ‘approved pharmacy’ means a pharmacy or class of pharmacies, approved in writing by the Chief Health Officer, which has a service room, consulting room, or area consistent with the following:
- •o the room or area is not to be used as a dispensary, storeroom, staff room or retail area,
- •o fully enclosed and provides adequate privacy (a divider or curtain in a dispensary, storeroom, staff room or retail area is not acceptable),
- •o has adequate lighting,
- •o is maintained at a comfortable ambient temperature,
- •o has a hand sanitisation facility,
- •o has ready access to a hand washing facility, and
Exclusion Criteria
- •Individuals outside the age range for each condition.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of a community pharmacist-led minor ailments service in collaboration with general practitioners: a cluster randomised controlled trialGastroesophageal refluxCoughCommon coldPrimary dysmenorrhoeaTension headacheMigraineNon specific low back painOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesReproductive Health and Childbirth - Menstruation and menopauseNeurological - Other neurological disordersMusculoskeletal - Other muscular and skeletal disordersACTRN12618000286246niversity of Technology Sydney894
Not yet recruiting
Not Applicable
Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney diseasechronic kidney diseaseJPRN-UMIN000049814ational Hospital Organization Mie Chuo Medical Center40
Completed
Not Applicable
Assessment of community pharmacies' support for smoking cessation treatment in collaboration with medical institutionsSmoking cessationJPRN-UMIN000044380School of Pharmacy, Nihon University70
Recruiting
Not Applicable
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease ProjectACTRN12609000705280Monash450
Completed
Not Applicable
Evaluation of the use of a patient questionnaire in measuring patient reported outcomes of medication reviewsadverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)NL-OMON28732Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands200